Sleep Drugs: What Every Woman Should Know
The post below first appeared on Law Street. Sleepless nights; nights full of tossing and turning. It happens to all of us–but for some it’s more frequent than others. In fact, an estimated 50 to 70 million American adults suffer from sleep disorders like insomnia or obstructive sleep apnea. Many turn to prescription sleep medications for relief– but women are more likely to take sleep drugs than men. About 3.1 percent of American men and 5 percent of American women report having used a prescription sleep medication within the last 30 days. What does this use of sleep aids me...
Source: Disruptive Women in Health Care - May 11, 2016 Category: Consumer Health News Authors: dw at disruptivewomen.net Tags: Women's Health Source Type: blogs

Merck to Dole Out $100 Million in NuvaRing Settlement
Merck & Co. agreed Friday to pay $100 million in product liability lawsuits that claimed its birth control product NuvaRing caused blood clots that led in some instances to fatal heart attacks, Reuters reports.NuvaRing, a vaginal ring that acts as a hormonal contraceptive and contains estrogen and progestin as commonly found in birth control pills, has been associated with an increased risk of developing blood clots that can cause heart attack, stroke, or sudden death.Merck, which is the second-largest drug manufacturer in the U.S., denied any fault under the agreement. But 3,000 people are eligible to participate in t...
Source: PharmaGossip - February 8, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs

A Court Ruling Against Merck May Also Hurt Pfizer
In a setback for Merck, a federal judge refused to dismiss a whistleblower lawsuit that accuses the drugmaker of distorting so-called nominal pricing in order to build a huge customer base for its Nuvaring contraception device and three contraceptive pills. The lawsuit, which was filed by two former employees, also claims the drugmaker offered kickbacks to physicians in exchange for prescribing a cancer medication. At issue is an alleged scheme in which Organon – which Merck (MRK) inherited as part of its 2009 purchase of Schering-Plough – offered a steep discount to Planned Parenthood for its contraceptive pro...
Source: Pharmalot - February 26, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized Birth Control Pills Contraception Contraceptives Medicaid Merck Nuvaring Organon Pfizer Planned Parentood Schering Plough Wyeth Source Type: blogs